
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🕒 May 18
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
• Serve as the physician lead for CAR T-cell therapy clinical trials in autoimmune disease indications, in partnership with internal and external cross-functional teams. • Oversee medical monitoring of clinical trials, including engagement with site investigators and external medical monitors. • Partner with clinical operations, biometrics, regulatory, and commercial teams to ensure alignment on strategy and execution. • Lead design, execution, and interpretation of clinical trials across assigned program. • Provide medical and scientific input into clinical development plans, study protocols, investigator brochures, and regulatory submissions. • Medical review, analysis, and interpretation of safety, efficacy, and PK and biomarker data. • Development of clinical trial documents including protocols, ICFs, clinical development plans, and publications. • Lead the development of clinical sections of regulatory documents including the IB, safety updates, clinical study reports, and responses to Health Authorities. • Actively engage with external investigators and researchers to identify, evaluate, and support investigator sponsored studies and drive research collaborations.
• MD, DO, (or ex-US equivalent) or MD-PhD degree required. • 5+ years of clinical research experience with 3+ years of industry experience in late phase clinical development involved in the design and execution of clinical trials. Experience in late-stage clinical development preferred. • Specialty training in neurology, rheumatology, nephrology and/or industry experience in clinical development of cell therapies and/or therapies for autoimmune diseases is highly preferred. • Proven ability to interpret, discuss and present efficacy and safety data. • Strong knowledge of GCP/ICH, clinical trial design, clinical development processes, and regulatory requirements. • Strong ability to communicate and establish effective working relationship with investigators, collaborators, scientific advisors, CROs, and corporate partners.
• annual salary in the range of $330,000 to $370,000 • bonus eligibility • participation in the Company’s stock plan
Apply Now🕒 May 18
Medical Director/Senior Medical Director in Clinical Development for Cullinan Therapeutics. Leading clinical trials and collaborating on a T-cell engager program for AML.
🇺🇸 United States – Remote
💵 $300k - $390k / year
💰 $10M Post-IPO Equity on 2022-03
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
🕒 May 14
Medical Director overseeing medical aspects of clinical trials at Thermo Fisher Scientific. Ensuring compliance with regulations and delivering high-quality medical oversight in the pharmaceutical product life-cycle.
🕒 May 13
Medical Director/Senior Medical Director overseeing safety in clinical studies at Neumora. Driving pharmacovigilance operations and collaborating with various clinical functions.
🕒 May 9
Market Physician Executive leading the in-home multi-specialty polychronic care model with focus on quality outcomes. Collaborating with health teams to improve patient well-being and reduce costs.
🕒 May 9
Market Physician Executive leading in-home specialty care and improving patient outcomes at Monogram Health. Collaborating with specialists and overseeing clinical operations in an assigned market.